We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
-1.2%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$179M
AUM Growth
+$10.2M
Cap. Flow
+$12M
Cap. Flow %
6.7%
Top 10 Hldgs %
24.7%
Holding
154
New
12
Increased
93
Reduced
37
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 14.64%
2 Technology 13.14%
3 Industrials 12.23%
4 Financials 10.45%
5 Consumer Staples 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$175B
$2.16M 1.21%
43,964
+3,250
+8% +$156K
MRK icon
27
Merck
MRK
$315B
$2.16M 1.21%
39,694
+2,139
+6% +$120K
GILD icon
28
Gilead Sciences
GILD
$167B
$2.12M 1.18%
18,065
+117
+0.7% +$12.8K
MSFT icon
29
Microsoft
MSFT
$2.93T
$2.11M 1.18%
47,845
+2,898
+6% +$132K
INTC icon
30
Intel
INTC
$478B
$2.11M 1.18%
69,415
+1,109
+2% +$35.9K
AMT icon
31
American Tower
AMT
$79.2B
$2.11M 1.18%
22,607
+2,158
+11% +$204K
QCOM icon
32
Qualcomm
QCOM
$181B
$2.1M 1.17%
33,472
+976
+3% +$66.6K
GE icon
33
GE Aerospace
GE
$364B
$2.08M 1.17%
16,376
+414
+3% +$53.7K
KO icon
34
Coca-Cola
KO
$351B
$2.08M 1.16%
52,884
+478
+0.9% +$19.4K
VZ icon
35
Verizon
VZ
$182B
$2.06M 1.15%
44,273
+3,494
+9% +$171K
TMO icon
36
Thermo Fisher Scientific
TMO
$198B
$2M 1.12%
15,375
+1,215
+9% +$158K
CL icon
37
Colgate-Palmolive
CL
$74.4B
$1.8M 1.01%
27,548
+729
+3% +$49.5K
PM icon
38
Philip Morris
PM
$301B
$1.78M 0.99%
22,149
-128
-0.6% -$10.5K
BAX icon
39
Baxter International
BAX
$11.7B
$1.75M 0.98%
46,075
-2,728
-6% -$102K
EPD icon
40
Enterprise Products Partners
EPD
$82.6B
$1.61M 0.9%
53,820
+2,214
+4% +$72.5K
SLB icon
41
SLB Ltd
SLB
$70.3B
$1.61M 0.9%
18,640
+311
+2% +$28.1K
JPM icon
42
JPMorgan Chase
JPM
$907B
$1.58M 0.88%
23,321
+869
+4% +$56.7K
SBUX icon
43
Starbucks
SBUX
$120B
$1.54M 0.86%
28,759
-20,021
-41% -$1.02M
UNH icon
44
UnitedHealth
UNH
$387B
$1.35M 0.76%
11,100
+668
+6% +$79K
LMT icon
45
Lockheed Martin
LMT
$117B
$1.34M 0.75%
7,235
+305
+4% +$58.7K
SPY icon
46
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$1.34M 0.75%
6,524
+1,933
+42% +$406K
MA icon
47
Mastercard
MA
$480B
$1.3M 0.73%
13,958
-300
-2% -$27.5K
DWM icon
48
WisdomTree International Equity Fund
DWM
$665M
$1.28M 0.72%
25,081
+2,889
+13% +$155K
GIS icon
49
General Mills
GIS
$20.3B
$1.27M 0.71%
22,795
+1,312
+6% +$73.5K
PFE icon
50
Pfizer
PFE
$143B
$1.2M 0.67%
37,776
+2,025
+6% +$66K

Similar funds

Girard Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Girard Partners held 154 positions worth $179M, up 6.1% from $169M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Girard Partners deployed $12M of net new capital in Q2 2015, opening 12 new positions and adding to 93 existing holdings. Its largest new stake was PALL CORP: 6,000 shares worth $747K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Starbucks, an estimated $1.02M trimmed.

  • Girard Partners's largest Q2 2015 buy was PALL CORP: 6,000 shares worth $747K.
  • Girard Partners added most to Vanguard Small-Cap Value ETF in Q2 2015, an estimated $2.59M increase.
  • Girard Partners's biggest Q2 2015 reduction was Starbucks, cutting an estimated $1.02M.
  • Girard Partners fully exited Magellan Midstream Partners, L.P. in Q2 2015, selling an estimated $348K.
  • Girard Partners's ten largest holdings make up 25% of its $179M portfolio in Q2 2015.
  • Girard Partners opened 12 new positions and closed 6 in Q2 2015.
  • Girard Partners's portfolio value rose 6.1% quarter-over-quarter to $179M.

Based on Girard Partners's 13F filing for Q2 2015, filed 4 Aug 2015.